In this video, Alessandra Romano, MD, PhD, University of Catania, Catania, Italy, shares some insights into treatment approaches for systemic mastocytosis (SM), drawing focus on the role of avapritinib. Dr Romano first addresses the efficacy of avapritinib compared to midostaurin, and then discusses concerns about the toxicity of this agent, and the promise of other novel tyrosine kinase inhibitors (TKIs). This interview took place at the 4th Society of Hematologic Oncology (SOHO) Italy Annual Conference, held in Rome, Italy.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
